Samenvatting
Samenvatting medicatie en invasieve zorg
- Instelling
- Karel De Grote-Hogeschool (KdG)
Zie inhoudstafel op de voorbeeldpagina's van de samenvatting
[Meer zien]Voorbeeld 10 van de 66 pagina's
Voorbeeld 10 van de 66 pagina's
In winkelwagenVerkoper
Volgen
Voorbeeld van de inhoud
Medicatie en invasieve zorgGeneesmiddelen ..................................................................................................................10
Causale of essentiële therapie ......................................................................................10
Symptomatische therapie ..............................................................................................10
Substitutie of vervanging ...............................................................................................10
Profylactisch ..................................................................................................................10
Placebo .........................................................................................................................10
Diagnostisch..................................................................................................................10
Regel van 5 ......................................................................................................................11
toedieningswijzen .............................................................................................................11
Oraal .............................................................................................................................11
❖ Op basis van galenische vormen ........................................................................11
• Vaste vorm ......................................................................................................11
• Vloeibare vorm ................................................................................................11
❖ Op basis van vrijstelling ......................................................................................12
• Gewone vrijstelling ..........................................................................................12
• Gecontroleerde of gereguleerde vrijstelling .....................................................12
Rectaal en vaginaal .......................................................................................................12
Dermaal en transdermaal ..............................................................................................13
❖ Dermaal ..............................................................................................................13
• Vaste preparaten: ............................................................................................13
• Halfvaste preparaten: ......................................................................................13
• Vloeibare preparaten: ......................................................................................13
❖ Transdermaal .....................................................................................................13
Implantaat .....................................................................................................................14
Toedieningsvormen ..........................................................................................................14
Neus, oor en oog ...........................................................................................................14
Inhalatie ........................................................................................................................14
❖ Dosisaerosol .......................................................................................................14
❖ Poederinhalator ..................................................................................................14
❖ Oplossing voor verneveling (aerosol) ..................................................................14
Nevel .............................................................................................................................14
Injectievloeistof en infuus ..............................................................................................15
❖ Eisen voor infuusvloeistoffen ..............................................................................15
❖ Toedieningsweg..................................................................................................15
❖ Vrijstelling: ..........................................................................................................15
, Gasvorm: toedienen van zuurstof ..................................................................................15
Farmacokinetiek ...............................................................................................................16
Compartimentenmodel ..................................................................................................16
First pass model ............................................................................................................17
❖ Resorptie ............................................................................................................17
❖ Biologische beschikbaarheid...............................................................................17
❖ Distributie = Uitdelen...........................................................................................18
❖ Depots en eiwitbinding ........................................................................................18
❖ Eliminatie ............................................................................................................19
❖ Therapeutische bloedspiegel ..............................................................................19
Therapeutische, sub-therapeutische en toxische zone ..................................................20
Therapeutisch venster en optimale spiegel....................................................................20
Cumulatie ......................................................................................................................20
Opstart- en onderhoudsdosis ........................................................................................21
Beïnvloedingsfactoren ...................................................................................................21
❖ Ziektetoestanden ................................................................................................21
• Lever ...............................................................................................................21
• Nieren .............................................................................................................21
• Maagdarmstelsel .............................................................................................21
❖ Genetische factoren ............................................................................................21
❖ Interacties van geneesmiddelen .........................................................................21
❖ Lichaamsgewicht ................................................................................................22
❖ Omgevingsfactoren.............................................................................................22
Gevaren bij het gebruik van geneesmiddelen ................................................................22
❖ Allergie ...............................................................................................................22
❖ Ideosyncrasie .....................................................................................................22
❖ Intolerantie ..........................................................................................................22
❖ Sexuele dysfunctie..............................................................................................22
❖ Intoxicatie= vergiftiging .......................................................................................23
❖ Toxicomanie .......................................................................................................23
Bewaring...........................................................................................................................23
Vaste geneesmiddelen ..................................................................................................23
Vloeibare geneesmiddelen ............................................................................................24
Gasvormige geneesmiddelen ........................................................................................24
Verpakking........................................................................................................................24
Terugbetaling ....................................................................................................................24
Aandachtspunten ..............................................................................................................24
, bij ouderen ....................................................................................................................24
bij kinderen ....................................................................................................................25
❖ Effect en dosis ....................................................................................................25
❖ Leeftijd ................................................................................................................25
bij zwangere en zogende patiënten ...............................................................................25
bij verschil in etniciteit ....................................................................................................25
Verantwoordelijkheid.........................................................................................................25
Farmacovigilantie= Geneesmiddelenbewaking .................................................................25
protocollen ........................................................................................................................26
toedienen van medicatie................................................................................................26
❖ rapportage ..........................................................................................................26
Toedienen van zuurstof .................................................................................................26
❖ Voorkomen van zuurstof in de verpleegkundige praktijk: ....................................26
• Gasflessen: .....................................................................................................26
❖ Berekenen van de inhoud van zuurstofcilinders ..................................................26
❖ Oorzaken van zuurstoftekort: ..............................................................................26
❖ Plots of geleidelijk tekort .....................................................................................27
• Zuurstoftekort kan plots optreden ....................................................................27
• Zuurstoftekort kan geleidelijk optreden ............................................................27
❖ Algemene symptomen van zuurstoftekort: ..........................................................27
• Symptomen van langzaam zuurstoftekort........................................................27
• Symptomen van chronisch zuurstoftekort → COPD ........................................27
• Fysiologie bij chronisch zuurstoftekort → complicatie ......................................27
❖ Veiligheid ............................................................................................................27
• Rookverbod .....................................................................................................27
• Open vuur: ......................................................................................................27
• Ontstekingsbronnen: .......................................................................................28
• Koppelstukken:................................................................................................28
• Vetten en oliën: ...............................................................................................28
Gasvorm: Zuurstof.........................................................................................................28
❖ Toe te dienen hoeveelheid zuurstof ....................................................................28
❖ Verpleegkundige aandachtspunten bij zuurstoftoediening: .................................28
❖ Toedieningsmethoden ........................................................................................28
• Toediening via nasofaryngeale katheter ..........................................................28
• Toediening via zuurstofbril...............................................................................29
• Toediening via zuurstofmasker ........................................................................29
• Toediening via zuurstoftent .............................................................................29
, • Toediening via (hyperbare)zuurstofkamer .......................................................29
• Toediening via kunstmatige beademing ..........................................................29
• Toediening via incubator .................................................................................29
Inspuiting ..............................................................................................................................30
Definitie.............................................................................................................................30
Indicaties ..........................................................................................................................30
Soorten .............................................................................................................................30
Door verpleegkundigen .................................................................................................30
Door arts met assistentie van verpleegkundigen ...........................................................30
Materiaal ...........................................................................................................................30
Spuiten: .........................................................................................................................30
Naalden: ........................................................................................................................30
Geneesmiddel: ..............................................................................................................31
Gevaren ............................................................................................................................31
Voor de patiënt: .............................................................................................................31
Voor de verpleegkundige:..............................................................................................31
❖ Prikaccident ........................................................................................................31
Intramusculaire inspuiting .................................................................................................31
Voorwaarden: ................................................................................................................31
Plaatsen: .......................................................................................................................31
❖ m. gluteus ...........................................................................................................31
• gluteus maximus .............................................................................................31
• gluteus medius ................................................................................................32
❖ m. deltoides= deltaspier ......................................................................................32
❖ m. quadriceps femoris= vierhoofdige dijspier ......................................................33
complicaties ..................................................................................................................33
Zigzagmethode of Z-track..............................................................................................33
Versteken ......................................................................................................................34
Subcutaan ........................................................................................................................34
Indicaties: ......................................................................................................................34
Plaatsen: .......................................................................................................................34
Techniek:.......................................................................................................................34
❖ Afhankelijk van de naald: ....................................................................................34
• korte SC naald (+/- 10 mm) .............................................................................34
• lange SC naald (+/- 25 mm) ............................................................................34
complicaties = gevaren..................................................................................................35
Anticoagulantia therapie ................................................................................................35
, intradermaal ......................................................................................................................35
Indicaties: ......................................................................................................................35
Plaats: ...........................................................................................................................35
Aandachtspunten bij toediening ........................................................................................35
Bloedafname ........................................................................................................................36
bepaling ............................................................................................................................36
bloedafname is ..............................................................................................................36
doel...................................................................................................................................36
Proefpunctie: .................................................................................................................36
Evacuerende punctie: ....................................................................................................36
❖ aderlating= derivatie ...........................................................................................36
❖ Wisseltransfusie..................................................................................................36
soorten bloedonderzoek ...................................................................................................36
Onderzoeken op bloed met anticoagulantia...................................................................36
❖ EDTA= Ethyleen Diamine Tetra Acetaat .............................................................36
• Cytologisch onderzoek ....................................................................................37
• Bloedgroep: 4 systemen..................................................................................37
❖ natriumcitraat ......................................................................................................38
• Sedimentatie ...................................................................................................38
• Bloedstollingstesten ........................................................................................39
❖ heparine .............................................................................................................39
• pH ...................................................................................................................39
• Bloedgassen ...................................................................................................39
• L.E. cellen = Lupus erythematodes cellen .......................................................39
❖ kaliumoxalaat + natriumfluoride ..........................................................................39
Onderzoeken op gestold bloed (serum) .........................................................................39
❖ Ionen → Ionogram ..............................................................................................39
❖ Ijzer.....................................................................................................................40
❖ Serumeiwitten of Proteïnen .................................................................................40
❖ enzymen .............................................................................................................40
• Transaminase .................................................................................................40
• Fosfatasen ......................................................................................................40
• LDH: ................................................................................................................40
• Gamma GT: ....................................................................................................40
❖ Lipiden ................................................................................................................40
❖ Substraten ..........................................................................................................41
❖ Toxicologie .........................................................................................................41
, ❖ Immunologie .......................................................................................................41
❖ Hormonologie .....................................................................................................42
Speciale onderzoeken ...................................................................................................42
❖ Bloedingstijd = Dukes test...................................................................................42
❖ Hemoculturen: ....................................................................................................42
venapunctie ...................................................................................................................42
❖ Materiaal .............................................................................................................42
Bloedafname .................................................................................................................43
❖ Tijdstip van afname en bewaring ........................................................................43
❖ aderkeuze ...........................................................................................................43
❖ Aanleggen afbindsnoer .......................................................................................43
❖ Verwikkelingen voorkomen .................................................................................43
❖ Pediatrische aspecten en aanpassingen .............................................................44
❖ Geriatrische aspecten en aanpassingen .............................................................44
Bloedwaarden ...............................................................................................................44
❖ Overzicht van de bloedcellen ..............................................................................44
Infusen .................................................................................................................................44
Toedieningswegen ............................................................................................................44
Perifeer: ........................................................................................................................44
Centraal: .......................................................................................................................44
Infusie: Aanwijzingen: doel................................................................................................45
Soorten oplossingen .........................................................................................................45
Volgens osmotische druk ..............................................................................................45
❖ Osmose: .............................................................................................................45
❖ Osmotische druk: ................................................................................................45
❖ Isotone oplossing: ...............................................................................................45
❖ Hypertone oplossing ...........................................................................................45
❖ Hypotone oplossing ............................................................................................45
❖ Colloïdale oplossingen ........................................................................................46
❖ Op infuuszak altijd vermeld: ................................................................................46
Volgens samenstelling...................................................................................................46
❖ Elektrolyten zonder calorietoevoer ......................................................................46
❖ Oplossingen met calorietoevoer..........................................................................46
• Suikeroplossingen zonder elektrolyten ............................................................46
• Elektrolyten met calorieën ...............................................................................47
❖ Eiwitoplossingen .................................................................................................47
❖ vetoplossingen ....................................................................................................47
, ❖ Colloïdale oplossingen ........................................................................................47
Infusie: materialen ............................................................................................................47
Verpakking vloeistof: .....................................................................................................47
Toedieningssysteem: ....................................................................................................48
Hulpstukken: .................................................................................................................48
Inbrengmateriaal: ..........................................................................................................48
regelsysteem .................................................................................................................48
Verbandmateriaal ..........................................................................................................48
Inloopsnelheid...................................................................................................................48
Aandachtspunten: .........................................................................................................48
❖ Overvulling..........................................................................................................48
❖ Ondervulling .......................................................................................................48
❖ Niet lopen van het infuus ....................................................................................49
Druppels per minuut: .....................................................................................................49
Milliliter per uur: .............................................................................................................49
Punctieplaats.................................................................................................................50
Infusie: complicaties..........................................................................................................50
Verpleegkundige aandachtspunten bij lucht in de leiding...............................................51
❖ Bij zeer weinig lucht in de leiding ........................................................................51
❖ Bij veel lucht in de leiding ....................................................................................51
infusie en medicatie ..........................................................................................................51
Continu ..........................................................................................................................51
Periodisch .....................................................................................................................51
Diabetes ...............................................................................................................................52
basiskennis .......................................................................................................................52
definitie ..........................................................................................................................52
Verminderde insulineproductie ......................................................................................52
Insuline resistentie.........................................................................................................52
bloedwaarden ................................................................................................................52
❖ Normaal ..............................................................................................................52
❖ Hyperglycemie ....................................................................................................52
❖ hypoglycemie ......................................................................................................53
Soorten diabetes ...........................................................................................................53
❖ Type 1 ................................................................................................................53
❖ Type 2 ................................................................................................................54
❖ Zwangerschapsdiabetes .....................................................................................54
Behandeling ......................................................................................................................54
, Bloedsuikerverlagende middelen ...................................................................................54
Aanpassing levensstijl ...................................................................................................54
acute complicaties ............................................................................................................55
Hypoglycemie................................................................................................................55
❖ Oorzaken ............................................................................................................55
❖ symptomen .........................................................................................................55
• Autonome symptomen ....................................................................................55
• Neuroglycopenische symptomen.....................................................................55
❖ Verpleegkundige aandachtspunten .....................................................................55
• Bewuste patiënt...............................................................................................56
• Onbewuste patiënt ..........................................................................................56
Hyperglycemie ..............................................................................................................56
❖ Oorzaken ............................................................................................................56
❖ Symptomen ........................................................................................................56
❖ Verpleegkundige aandachtspunten .....................................................................56
Keto-acidose .................................................................................................................56
Onderzoeken ....................................................................................................................57
Capillaire bloedafname ..................................................................................................57
❖ Materiaal .............................................................................................................57
• Prikmateriaal ...................................................................................................57
• teststrookjes ....................................................................................................57
• glucosemeter...................................................................................................57
❖ Factoren die de meting beïnvloeden ...................................................................57
perifere bloedafname ....................................................................................................57
❖ glycemiemeting ...................................................................................................57
• Klinisch belang ................................................................................................57
Glucose dagprofiel of dagcurve .....................................................................................57
Orale Glucose Tolerantie test (OGTT) ...........................................................................58
Hemoglobine A1c (HbA1c) ............................................................................................58
Urineonderzoeken .........................................................................................................58
insuline .............................................................................................................................58
soorten ..........................................................................................................................58
❖ Oorsprong...........................................................................................................58
• Humane insuline .............................................................................................58
• Analoge insuline ..............................................................................................58
• Verschil ...........................................................................................................58
❖ werkingsprofiel ....................................................................................................59
, • Snelwerkend ...................................................................................................59
• traagwerkend = basale insuline .......................................................................60
• Gemengde werking .........................................................................................61
Bijspuitschema ..............................................................................................................62
❖ Voorbeelden .......................................................................................................62
• Hele actrapidregel: ..........................................................................................62
• Halve actrapidregel: ........................................................................................62
Verpakkingen ................................................................................................................62
Bewaring .......................................................................................................................62
❖ Ongeopend .........................................................................................................62
❖ Geopend .............................................................................................................62
❖ Let op .................................................................................................................62
mengen in & spuit..........................................................................................................63
Toedieningsmateriaal ....................................................................................................63
Insulinepomp .................................................................................................................63
❖ Wat: ....................................................................................................................63
Injectieplaatsen .............................................................................................................63
❖ Buik: ...................................................................................................................63
❖ Dij: ......................................................................................................................63
❖ Bil: ......................................................................................................................64
❖ Arm: ....................................................................................................................64
❖ De resorptie van insuline wordt beïnvloed door ..................................................64
Verpleegkundige aandachtspunten ...............................................................................64
Rotatieschema ..............................................................................................................64
Injectietechniek .............................................................................................................64
Weefselbeschadiging ....................................................................................................65
Intraveneuze toediening ................................................................................................65
❖ Gebruik ...............................................................................................................65
Chronische verwikkelingen ...............................................................................................65
Macro-angiopathie.........................................................................................................65
Micro-angiopathie ..........................................................................................................65
Neuropathie...................................................................................................................66
Diabetesvoet .................................................................................................................66
Situatie gebonden aspecten..............................................................................................66
Pediatrische aspecten ...................................................................................................66
Geriatrische aspecten ...................................................................................................66
, Medicatie en invasieve zorg
Geneesmiddelen
Inleiding
Definitie
➢ Het is een Preparaat:
o Plantaardige oorsprong
o Dierlijke oorsprong
o Synthetische oorsprong
➢ Het dient op Ziekte:
o Voorkomen
o Genezen
o verzachten
➢ het dient om Diagnose stellen
Afkomst
➢ Overlevering door de natuurproducten (tijdens WOII)
➢ Toevallige ontdekking vb. penicilline en orale anticoagulantia
➢ Gericht onderzoek
➢ Alternatieve geneesmiddelen
Indeling
Causale of essentiële therapie
➢ Geneesmiddelen die de oorzaak van de ziekte bestrijden
➢ Vb. antibioticum
Symptomatische therapie
➢ Geneesmiddelen die de verschijnselen van een ziekte (pijn, misselijkheid, braken,
jeuk) bestrijden
➢ Vb. Dafalgan, Primperan
Substitutie of vervanging
➢ Geneesmiddelen die een stof die voor het lichaam onmisbaar is vervangen of
aanvullen
➢ Vb. hormonen, vitaminen
Profylactisch
➢ Geneesmiddelen die dienen ter voorkoming van ziekten.
➢ Vb. vaccinatie, …
Placebo
➢ De gesuggereerde (voorgestelde) werking ( het placebo-effect) is onafhankelijk van
het toegediende geneesmiddel. Je krijgt een bepaald geneesmiddel maar de nodige
werkzame stof zit er niet in.
Diagnostisch
➢ contraststoffen geven om galwegen, bloedvaten … op RX te kunnen weergeven
Voordelen van het kopen van samenvattingen bij Stuvia op een rij:
√ Verzekerd van kwaliteit door reviews
Stuvia-klanten hebben meer dan 700.000 samenvattingen beoordeeld. Zo weet je zeker dat je de beste documenten koopt!
Snel en makkelijk kopen
Je betaalt supersnel en eenmalig met iDeal, Bancontact of creditcard voor de samenvatting. Zonder lidmaatschap.
Focus op de essentie
Samenvattingen worden geschreven voor en door anderen. Daarom zijn de samenvattingen altijd betrouwbaar en actueel. Zo kom je snel tot de kern!
Veelgestelde vragen
Wat krijg ik als ik dit document koop?
Je krijgt een PDF, die direct beschikbaar is na je aankoop. Het gekochte document is altijd, overal en oneindig toegankelijk via je profiel.
Tevredenheidsgarantie: hoe werkt dat?
Onze tevredenheidsgarantie zorgt ervoor dat je altijd een studiedocument vindt dat goed bij je past. Je vult een formulier in en onze klantenservice regelt de rest.
Van wie koop ik deze samenvatting?
Stuvia is een marktplaats, je koop dit document dus niet van ons, maar van verkoper sandydaems. Stuvia faciliteert de betaling aan de verkoper.
Zit ik meteen vast aan een abonnement?
Nee, je koopt alleen deze samenvatting voor €3,99. Je zit daarna nergens aan vast.
Is Stuvia te vertrouwen?
4,6 sterren op Google & Trustpilot (+1000 reviews)
Afgelopen 30 dagen zijn er 67474 samenvattingen verkocht
Opgericht in 2010, al 14 jaar dé plek om samenvattingen te kopen